State Street's PRIV Misses Mark on Private Credit Promise
The recently launched SPDR SSGA Apollo IG Public & Private Credit ETF (PRIV) garnered widespread attention for its groundbreaking approach to private credit investing, but analysis reveals a gap between its marketing and reality.
According to a research report from CFRA, the fund received Securities and Exchange Commission approval to exceed the standard 15% limit on illiquid securities stipulated in the Investment Company Act of 1940. Investors anticipated PRIV would hold between 10% and 35% of its portfolio in private credit instruments.
Despite regulatory permission to increase private credit exposure beyond traditional limits, PRIV currently holds just 5% of its portfolio in private credit assets, according to CFRA, with the vast majority in highly liquid public securities that offer little differentiation from conventional fixed-income ETFs.
The fund's current portfolio differs from the private credit focus many expected. CFRA's analysis shows 42% of PRIV's exposure is in public corporate debt, with another 19% in securitized agency mortgages and 15% in Treasuries or cash instruments.
"While this ensures that its portfolio is liquid, it also makes it less differentiated relative to other fixed-income funds, since its constituents are widely held by mutual funds and other ETFs," wrote Aniket Ullal, head of ETF research at CFRA, and Sourav Srimal, senior vice president of solutions at SOLVE, in their joint report.
The liquidity profile further underscores how conventional PRIV's current holdings are. Over 75% of the portfolio is classified as liquid, with 62% rated as highly liquid, based on Trade Reporting and Compliance Engine data aggregated by SOLVE.
This liquidity composition contrasts with other private credit options like the BondBloxx Private Credit CLO ETF (PCMM) and VanEck BDC Income ETF (BIZD), which have fewer holders of their underlying securities, the report shows.
On average, PRIV's constituents are held by 110 other mutual funds, exchange-traded funds or insurance firms, while PCMM's holdings average just four other holders, the report stated. Only 11% of PRIV's constituents were held by fewer than 10 other investment vehicles.
The fund's yield reflects its conventional portfolio composition. PRIV's published yield to maturity, as of March 3, was 5.44%, lower than BIZD's 9.02% and PCMM's 7.44% 30-day SEC yields.
PRIV's arrangement with Apollo Global Securities, which contractually agreed to provide intraday executable bids on private credit investments, appears largely unused given the fund's current highly liquid portfolio composition, according to the CFRA report.
The report suggests that the ETF's composition could evolve: "Going forward, it seems likely that this actively managed ETF will start to take on more private credit that is sourced from Apollo."
The agreement requires Apollo to publish three executable quotation sheets daily to buy PRIV-held securities sourced from Apollo, with quotes "no worse than those offered to similarly situated clients," according to the CFRA analysis.Permalink | © Copyright 2025 etf.com. All rights reserved
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
MediPharm Labs' Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as Dissident
McCutcheon Agrees with Apollo that Urgent Change is Needed, including Complete Turnover at the Board Level after Years of Value-Destruction Apollo Capital Announces Filing of Circular Addendum to Reflect McCutcheon's EndorsementTORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Apollo Technology Capital Corporation ("Apollo Capital"), one of MediPharm Lab Corp's (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ('MediPharm', or the 'Company') largest investors, is very pleased to announce that Pat McCutcheon, a founder, former CEO, director and Chairman of MediPharm, has joined Apollo Capital as a co-dissident in its battle to bring integrity, transparency and prosperity back to MediPharm's long-suffering shareholders. Pat McCutcheon stated: 'I have been observing Apollo's activist campaign from the sidelines, and I can no longer just sit by and watch. I still feel a deep responsibility to the Company, its employees and the shareholders who have invested millions into the vision of MediPharm being the global leader in medical cannabis and cannabis derived pharmaceutical products. Over the past three years, the share price has collapsed while the senior management team has been paid over $10,000,000, a compensation program that should never have been approved by the independent Directors. Management has failed to capitalize on the medical cannabis opportunity and taken the Company away from its founding vision by entering the recreational market, taking on dilutive M&A transactions and recently announcing a return to cultivating cannabis. This is not the MediPharm investors have supported. I have gotten to know Regan McGee & his team of proposed directors. The directors have a broad range of relevant experience including medical cannabis experience, turn-around experience, and extensive capital markets experience. Regan has demonstrated himself to be a skilled investor who has been successful in both start-ups and turn-around projects. He's also overcome great personal adversity, showing that he never backs down from a fight. In terms of the negative statements from MediPharm about Regan, the ones that I have been able to independently verify have turned out to be simply fabrications that appear to be part of MediPharm's campaign to discredit and defame Regan. I believe the attacks on Regan & his business record are not factual and more importantly hide the real issues that shareholders should be considering such as compensation, dilution & the share price. On each of these fronts, I believe the Apollo directors are a better choice than the directors put forward by the current Board. We need to focus on the real issues – who is going to drive the stock price higher. Apollo only makes money when the stock price goes up, as all the shareholders do together. This is why I support the Apollo team. I'm asking shareholders to vote GOLD at this year's AGM. We do not have time to wait.' Apollo notes that its business model with MediPharm is highly aligned with shareholders. As an activist investor, it looks to make investments in poorly managed companies where new governance and management can work to improve the share price for Apollo and all other investors. Apollo's business model is to buy stock in target companies and work with frustrated shareholders to secure the majority of votes needed to replace board members and executives with ones focused on share value growth. Apollo does not 'take over' or otherwise control its target companies, rather it appoints directors who recognize their legal fiduciary duty to act in the best interests of all common shareholders. Regan McGee of Apollo Capital commented: 'We are immensely proud to welcome Pat McCutcheon as a co-dissident. Pat is responsible for helping to build MediPharm into an absolute powerhouse in the cannabis industry, and I can only imagine how difficult it has been for him to watch the Company he loves so much be mismanaged virtually to the point of insolvency. Pat and I want exactly the same thing – to restore value to MediPharm shareholders and to usher in a new era of profitability, good governance and most importantly, accountability. We both believe that if we all come together and take urgent action, the future for the MediPharm will be bright.' In connection with the addition of Mr. McCutcheon as a 'dissident' within the meaning of applicable corporate laws, an addendum dated June 4, 2025 (the 'Addendum') to the dissident information circular dated May 15, 2025 (the 'Circular') has been filed on under MediPharm's profile. Shareholders are encouraged to read the Circular, as supplemented and amended by the Addendum. Apollo Capital's strategic five-pillar plan for MediPharm has been made available in detail at With shareholder support, we can turn MediPharm around and transform it into the world's leading medical cannabis company. Apollo Capital urges shareholders to vote for change by voting the GOLD CARD by June 12, 2025. Shareholders are urged NOT to sign or return the green proxy cards sent by the Company. Contacts For Shareholders:Carson ProxyNorth American Toll-Free Phone: 1-800-530-5189Local or Text Message: 416-751-2066 (collect calls accepted)E: info@ For Media:media@ This solicitation is being made by and on behalf of the Concerned Shareholder, who, as of the date of this Circular, beneficially owns or controls, directly and indirectly through its wholly-owned subsidiary, Nobul Technologies Inc., 12,491,500 common shares of the Company ('Common Shares'), representing approximately 3% of the total Common Shares issued and outstanding, and not by the management of the Company ('Management'). Legal Disclosures Information in Support of Public Broadcast Exemption under Canadian Law In connection with the annual general and special meeting (the 'Annual Meeting') of shareholders of MediPharm, Apollo Capital has filed an amended and restated dissident information circular dated May 15, 2025 (the 'Circular'), as amended and supplemented by an addendum to the Circular subsequently filed by Apollo Capital and Patrick McCutcheon (together, the 'Concerned Stakeholder') dated June 4, 2025 (the 'Addendum' and together with the Circular, the 'Amended Circular'), each in compliance with applicable corporate and securities laws. The Concerned Stakeholder has provided in, or incorporated by reference into, this press release the disclosure required under section 9.2(4) of NI 51-102 – Continuous Disclosure Obligations ('NI 51-102') and the corresponding exemption under the Business Corporations Act (Ontario), and has filed the Amended Circular, available under MediPharm's profile on SEDAR+ at The Amended Circular contains disclosure prescribed by applicable corporate law and disclosure required under section 9.2(6) of NI 51-102 in respect of the Concerned Stakeholder's director nominees, in accordance with corporate and securities laws applicable to public broadcast solicitations. The Amended Circular is hereby incorporated by reference into this press release and is available under MediPharm's profile on SEDAR+ at The registered office of the Company is 151 John Street, Barrie, Ontario, Canada L4N 2L1. SHAREHOLDERS OF MEDIPHARM ARE URGED TO READ THE AMENDED CIRCULAR CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION. Investors and shareholders are able to obtain free copies of the Amended Circular and any amendments or supplements thereto and further proxy circulars at no charge under MediPharm's profile on SEDAR+ at In addition, shareholders are also able to obtain free copies of the Amended Circular and other relevant documents by contacting the Concerned Stakeholder's proxy solicitor, Carson Proxy Advisors Ltd. ('Carson Proxy') at 1-800-530-5189, local (collect outside North America): 416-751-2066 or by email at info@ Proxies may be revoked in accordance with subsection 110(4) of the Business Corporations Act (Ontario) by a registered shareholder of Company shares: (a) by completing and signing a valid proxy bearing a later date and returning it in accordance with the instructions contained in the accompanying form of proxy; (b) by depositing an instrument in writing executed by the shareholder or by the shareholder's attorney authorized in writing; (c) by transmitting by telephonic or electronic means a revocation that is signed by electronic signature in accordance with applicable law, as the case may be: (i) at the registered office of the Company at any time up to and including the last business day preceding the day the Annual Meeting or any adjournment or postponement of the Annual Meeting is to be held, or (ii) with the chair of the Annual Meeting on the day of the Annual Meeting or any adjournment or postponement of the Annual Meeting; or (d) in any other manner permitted by law. In addition, proxies may be revoked by a non-registered holder of Company shares at any time by written notice to the intermediary in accordance with the instructions given to the non-registered holder by its intermediary. It should be noted that revocation of proxies or voting instructions by a non-registered holder can take several days or even longer to complete and, accordingly, any such revocation should be completed well in advance of the deadline prescribed in the form of proxy or voting instruction form to ensure it is given effect in respect of the Annual Meeting. The costs incurred in the preparation and mailing of any circular or proxy solicitation by the Concerned Stakeholder and any other participants named herein will be borne directly and indirectly by Apollo Capital. However, to the extent permitted under applicable law, Apollo Capital intends to seek reimbursement from the Company of all expenses incurred in connection with the solicitation of proxies for the election of its director nominees at the Annual Meeting. This press release and any solicitation made by the Concerned Stakeholder is, or will be, as applicable, made by such parties, and not by or on behalf of the management of the Company. Proxies may be solicited by proxy circular, mail, telephone, email or other electronic means, as well as by newspaper or other media advertising and in person by managers, directors, officers and employees of the Concerned Stakeholder who will not be specifically remunerated therefor. In addition, the Concerned Stakeholder may solicit proxies by way of public broadcast, including press release, speech or publication and any other manner permitted under applicable Canadian laws, and may engage the services of one or more agents and authorize other persons to assist it in soliciting proxies on their behalf. Apollo Capital has entered into an agreement with Carson Proxy for solicitation and advisory services in connection with the solicitation of proxies by the Concerned Stakeholder for the Annual Meeting, for which Carson Proxy will receive a fee from Apollo Capital not to exceed $250,000, together with reimbursement for reasonable and out-of-pocket expenses. Apollo Capital has also engaged Gasthalter & Co. LP ('G&Co') to act as communications consultant to provide the Concerned Stakeholder with certain communications, public relations and related services, for which G&Co will receive, from Apollo Capital, a minimum fee of US$75,000 in addition to a performance fee of US$250,000 in the event that the Concerned Stakeholder's nominees make up a majority of the board of directors of MediPharm (the 'Board') following the Annual Meeting, plus excess fees, related costs and expenses. No member of the Concerned Stakeholder nor any of their respective associates or affiliates has or has had any material interest, direct or indirect, in any transaction since the beginning of the Company's last completed financial year or in any proposed transaction that has materially affected or will or would materially affect the Company or any of the Company's affiliates. No member of the Concerned Stakeholder nor any of their respective associates or affiliates has any material interest, direct or indirect, by way of beneficial ownership of securities or otherwise, in any matter to be acted upon at the Annual Meeting, other than setting the number of directors and the election of directors to the Board. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward‐looking statements. All statements contained in this filing that are not clearly historical in nature or that necessarily depend on future events are forward‐looking, and the words 'anticipate,' 'believe,' 'expect,' 'estimate,' 'plan,' and similar expressions are generally intended to identify forward‐looking statements. These statements are based on current expectations of the Concerned Stakeholder and currently available information. They are not guarantees of future performance, involve certain risks and uncertainties that are difficult to predict, and are based upon assumptions as to future events that may not prove to be accurate. All forward-looking statements contained herein are made only as of the date hereof and the Concerned Stakeholder disclaims any intention or obligation to update or revise any such forward-looking statements to reflect events or circumstances that subsequently occur, or of which the Concerned Stakeholder hereafter becomes aware, except as required by applicable law. Hashtags: #ShareholderActivism #CorporateGovernance #InvestorProtection #Investor Alert #Investor Fraud #FinancialRegulation #CorporateCrime #FinancialCrime #HomelandSecurity #DHS #OpioidCrisis #OpioidEpidemic #OpioidLitigation #OpioidVictims #BMO #DEA #ONDCPSign in to access your portfolio
CNBC
2 hours ago
- CNBC
Apollo eyes $100 billion Germany investment as private capital swerves U.S. turmoil for Europe
MEGA, or "Make Europe Great Again," was a hot topic at this year's biggest private markets event last week. The about-turn in sentiment toward the continent was illustrated no better than when the boss of industry juggernaut Apollo said he saw the opportunity to put $100 billion "in the ground" in Germany over the next decade. "I think many investors in Europe see the opportunity, and many investors in U.S. see the opportunity right now in Europe. They see it across the private equity ecosystem. They also see it across the credit ecosystem," Apollo Global Management President Jim Zelter said during a keynote interview. As well as direct lending, Zelter said he saw big opportunity in investment-grade commercial and residential real estate, highlighting domestic housing shortages in Spain and the U.K. On Germany, Zelter said the $100 billion investment figure would be hard to match anywhere in the world outside of the U.S., and that the country had "woken up Europe to focus on financing industry, military and a variety of other critical industries." His comments will be welcomed by Germany's new government, which has called for private capital to help meet its infrastructure needs alongside public funding. Sentiment began to significantly shift around the sluggish German economy in March, when lawmakers approved alterations to longstanding debt restrictions to allow the establishment of a $500 billion fund for defense, infrastructure and climate-related projects. At the start of May, center-right, pro-business politician Friedrich Merz — who has served on the boards of BlackRock Germany, EY Germany and the Deutsche Börse — was confirmed as Germany's new chancellor, ending months of political uncertainty. Merz met with U.S. President Donald Trump last week , achieving some diplomatic wins in his attempt to strengthen ties between the countries and urge further support for Ukraine. Europe bulls, U.S. nerves Joana Rocha Scaff, head of European private equity at Neuberger Berman, told CNBC that many investors had started the year overweight the U.S. and intending to extend their allocations, expecting deregulation and a boost to economic growth, only to be abruptly stymied by Trump's tariff policies. "In the midst of this turbulence and noise in the U.S., we have seen capital be redirected towards Europe," she said, with her own investment firm "actively investing in the market" alongside its core general partners, or GPs. Neuberger Berman's active market investments deploy around $4 billion of capital on a direct basis a year, she said. So far this year, Europe has accounted for around 65% of direct investment activity, up from around 20-30% of global market activity on a typical year, she noted. Those investments have been broad, she continued but generally oriented around developed parts of Europe, energy security and transition, defense, digitalization and industrial assets. Private equity's enthusiasm toward Europe has also been reflected in public markets. Germany's blue chip DAX index is up around 22% this year, versus around 1% for the Dow Jones Industrial Average . Europe's Aerospace and Defense Index is up nearly 50%, while a tracker index of the long-buzzy Magnificent 7 U.S. tech giants is down 2%. For retail investors seeking opportunities in the space, JPMorgan recently named its top European stock picks for the next year — and they include defense names Rheinmetall and Babcock International , IT firms SAP and Dassault Systems , and infrastructure picks Alstom , Heidelberg Materials and Saint-Gobain . There are also new ways for retail investors to track private credit returns through exchange-traded funds — though experts warn private markets are complex and come with significant risks . Earlier this year, State Street and Apollo Global Management launched the SPDR SSGA Apollo IG Public & Private Credit ETF (PRIV) exchange-traded fund (ETF), which aims to have at least 80% of its assets in investment-grade private and public debt securities.
Yahoo
9 hours ago
- Yahoo
Collective Mining Announces the Appointment of Raphael Maracajá as Vice President Mining
TORONTO, June 9, 2025 /PRNewswire/ - Collective Mining Ltd. (NYSE: CNL) (TSX: CNL) ("Collective" or the "Company") is pleased to announce that Mr. Raphael Maracajá has been appointment as Vice President Mining, effective immediately. Mr. Maracajá is a senior mining professional with 20 years of international experience in both open pit and underground operations. He has held leadership roles in operations and technical services at companies such as Hudbay Minerals, Equinox Gold, Appian Capital and Yamana Gold. His expertise includes strategic mine planning, the implementation of new mining methods and systems and he has a proven track record of optimizing operations across North and South America. Mr. Maracajá holds a degree in Mining Engineering from the University of São Paulo, along with certifications from UBC, McGill, and CIM and is a prospective member of AusIMM. Ned Jalil, CEO of Collective commented: "I am delighted to welcome Raphael to the Collective team. Raphael's deep technical expertise, leadership experience, and proven ability to optimize complex mining operations across the Americas will be invaluable as we continue to advance our Guayabales and San Antonio projects. Raphael's appointment strengthens our ability to deliver on our growth strategy and reinforces our commitment to building a world-class mining company grounded in operational excellence and responsible development." 2025 Annual Shareholder Meeting Update Shareholders are reminded that the Company will hold its 2025 annual shareholder meeting on Monday June 16, 2025 at 9:30am ET (Toronto time). The Meeting will be held by way of Zoom video conference and the Company invites shareholders to participate in that manner where they will be permitted to ask questions and otherwise engage with the Company. To access the Meeting through Zoom, shareholders will need to download the application onto their computer or smartphone and once the application is loaded, open the following link: The Meeting ID is 864 7620 8646 and the Passcode is 322809. Shareholders are encouraged to vote their shares in accordance with the instructions as described in the Notice of Meeting and Management Information Circular. About Collective Mining Ltd. To see our latest corporate presentation and related information, please visit Founded by the team that developed and sold Continental Gold Inc. to Zijin Mining for approximately $2 billion in enterprise value, Collective is a gold, silver, copper and tungsten exploration company with projects in Caldas, Colombia. The Company has options to acquire 100% interests in two projects located directly within an established mining camp with ten fully permitted and operating mines. The Company's flagship project, Guayabales, is anchored by the Apollo system, which hosts the large-scale, bulk-tonnage and high-grade gold-silver-copper-tungsten Apollo system. The Company's objectives are to improve the overall grade of the Apollo system by systematically drill testing newly modeled potentially high-grade sub-zones, expand the Apollo system by stepping out along strike to the north and expanding the newly discovered high-grade Ramp Zone along strike and to depth, and drill a series of less advanced or newly generated targets including Trap, the Knife and X. Management, insiders, a strategic investor and close family and friends own 44.5% of the outstanding shares of the Company and as a result, are fully aligned with shareholders. The Company is listed on both the NYSE American and TSX under the trading symbol "CNL". Information Contact: Follow Executive Chairman Ari Sussman (@Ariski73) on X Follow Collective Mining (@CollectiveMini1) on X, (Collective Mining) on LinkedIn, and (@collectivemining) on Instagram FORWARD-LOOKING STATEMENTS This news release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable securities legislation (collectively, "forward-looking statements"). All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussion with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often, but not always using phrases such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the anticipated advancement of mineral properties or programs; future operations; future recovery metal recovery rates; future growth potential of Collective; and future development plans. These forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding future events including the direction of our business. Management believes that these assumptions are reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others: risks related to the speculative nature of the Company's business; the Company's formative stage of development; the Company's financial position; possible variations in mineralization, grade or recovery rates; actual results of current exploration activities; conclusions of future economic evaluations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; fluctuations in spot and forward prices of gold, precious and base metals or certain other commodities; fluctuations in currency markets; change in national and local government, legislation, taxation, controls regulations and political or economic developments; risks and hazards associated with the business of mineral exploration, development and mining (including environmental hazards, industrial accidents, unusual or unexpected formation pressures, cave-ins and flooding); inability to obtain adequate insurance to cover risks and hazards; the presence of laws and regulations that may impose restrictions on mining; employee relations; relationships with and claims by local communities and indigenous populations; availability of increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development (including the risks of obtaining necessary licenses, permits and approvals from government authorities); and title to properties, as well as those risk factors discussed or referred to in the annual information form of the Company dated March 24, 2025. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results, except as may be required by applicable securities laws. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements and there may be other factors that cause results not to be anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements. View original content to download multimedia: SOURCE Collective Mining Ltd.
